Oral Rivaroxaban for Symptomatic Venous
๐
Article
๐
2010
๐
Massachusetts Medical Society
๐
English
โ 698 KB
Background Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein thrombosis (DVT) and for continued treatment, without the need for laboratory monitoring. Methods We conducted an open-label, randomized, event-driven, noninferiority study that